These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 8205303

  • 1. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P, Ulicna L, Jakubovska Z, Oravcova J, Fetkovska N.
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [Abstract] [Full Text] [Related]

  • 2. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
    Tison P, Ulicna L, Jakubovska Z, Oravcova J, Fetkovska N.
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):46S-49S. PubMed ID: 7946179
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hypertension with calcium antagonists and aspirin. Effects on 24-h platelet activity.
    Fetkovska N, Jakubovska Z, Oravcova J, Tison P, Ulicna L, Trnovec T.
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):98S-101S. PubMed ID: 8466742
    [Abstract] [Full Text] [Related]

  • 4. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW, Welzel D, Burger KJ.
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [Abstract] [Full Text] [Related]

  • 5. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N, Sebekova K, Fedelesova V, Dzurik R.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P, Meisner W, Hitzenberger G.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [Abstract] [Full Text] [Related]

  • 7. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
    Ding YA, Han CL, Chou TC, Lai WY, Shiao MF.
    J Cardiovasc Pharmacol; 1992 May; 19 Suppl 3():S32-7. PubMed ID: 1376832
    [Abstract] [Full Text] [Related]

  • 8. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ, Anlauf M.
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [Abstract] [Full Text] [Related]

  • 9. [Multicenter study of isradipine in the treatment of hypertension].
    Widimský J, Dzúrik R, Fet'kovská N, Balazovjech I, Kvasnicka J, Lupínek Z, Mayer O, Pidrman V.
    Vnitr Lek; 1992 Apr; 38(4):317-25. PubMed ID: 1352927
    [Abstract] [Full Text] [Related]

  • 10. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A, Dartayet B, Ruegg C, Samii K.
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [Abstract] [Full Text] [Related]

  • 11. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ, Dehner R.
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [Abstract] [Full Text] [Related]

  • 12. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR, Laszt A, Farragi D.
    J Cardiovasc Pharmacol; 1991 Jun; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [Abstract] [Full Text] [Related]

  • 13. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X, Gong L, Guo J, Wang X, Liu Y, Ye X, Zhang G, Yang P.
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [Abstract] [Full Text] [Related]

  • 14. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
    Jern S, Hansson L, Scherstén B, Kullman S, Sörensen S, Dahlöf B, Eggertsen R, Sivertsson R.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 3():S7-8. PubMed ID: 1720487
    [Abstract] [Full Text] [Related]

  • 15. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF, Waeber B.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [Abstract] [Full Text] [Related]

  • 16. Reduced platelet thromboxane formation after long-term administration of a dihydropyridine calcium channel blocker: a prospective, double-blind, placebo-controlled study with nitrendipine in borderline hypertensive patients with IDDM-type diabetes mellitus.
    Tschoepe D, Homberg M, Roesen P, Gries FA.
    Diabetes Res; 1992 Mar; 19(3):125-31. PubMed ID: 1286547
    [Abstract] [Full Text] [Related]

  • 17. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K, Gleerup G, Hedner T.
    J Cardiovasc Pharmacol; 1991 Mar; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [Abstract] [Full Text] [Related]

  • 18. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B, Andrén L, Eggertsen R, Jern S, Svensson A, Sievert A, Aurell M, Hansson L.
    J Cardiovasc Pharmacol; 1987 Mar; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [Abstract] [Full Text] [Related]

  • 19. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R, Speiser P, Gisinger C, Schernthaner G, Prager R.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [Abstract] [Full Text] [Related]

  • 20. Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension.
    Muneta S, Kohara K, Hiwada K.
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):141-7. PubMed ID: 10190762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.